|
1
|
Hundahl SA, Fleming ID, Fremgen AM and
Menck HR: A National Cancer Data Base report on 53,856 cases of
thyroid carcinoma treated in the U.S., 1985–1995 [see comments].
Cancer. 83:2638–2648. 1998.PubMed/NCBI
|
|
2
|
Dohan O, Baloch Z, Banrevi Z, Livolsi V
and Carrasco N: Rapid communication: predominant intracellular
overexpression of the Na(+)/I(−) symporter (NIS) in a large
sampling of thyroid cancer cases. J Clin Endocrinol Metab.
86:2697–2700. 2001.PubMed/NCBI
|
|
3
|
Kondo T, Ezzat S and Asa SL: Pathogenetic
mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer.
6:292–306. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Grubbs EG, Rich TA, Li G, Sturgis EM,
Younes MN, et al: Recent advances in thyroid cancer. Curr Probl
Surg. 45:156–250. 2008. View Article : Google Scholar
|
|
5
|
Malchoff CD and Malchoff DM: Familial
nonmedullary thyroid carcinoma. Cancer Control. 13:106–110.
2006.PubMed/NCBI
|
|
6
|
Sturgis EM and Li G: Molecular
epidemiology of papillary thyroid cancer: in search of common
genetic associations. Thyroid. 19:1031–1034. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ducy P and Karsenty G: The family of bone
morphogenetic proteins. Kidney Int. 57:2207–2214. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nosho K, Yamamoto H, Adachi Y, Endo T,
Hinoda Y, et al: Gene expression profiling of colorectal adenomas
and early invasive carcinomas by cDNA array analysis. Br J Cancer.
92:1193–1200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Koehler A, Bataille F, Schmid C, Ruemmele
P, Waldeck A, et al: Gene expression profiling of colorectal cancer
and metastases divides tumours according to their
clinicopathological stage. J Pathol. 204:65–74. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kraunz KS, Nelson HH, Liu M, Wiencke JK
and Kelsey KT: Interaction between the bone morphogenetic proteins
and Ras/MAP-kinase signalling pathways in lung cancer. Br J Cancer.
93:949–952. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Beck SE and Carethers JM: BMP suppresses
PTEN expression via RAS/ERK signaling. Cancer Biol Ther.
6:1313–1317. 2007.PubMed/NCBI
|
|
12
|
Beck SE, Jung BH, Del Rosario E, Gomez J
and Carethers JM: BMP-induced growth suppression in colon cancer
cells is mediated by p21WAF1 stabilization and modulated by
RAS/ERK. Cell Signal. 19:1465–1472. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tomlinson IP, Carvajal-Carmona LG, Dobbins
SE, Tenesa A, Jones AM, et al: Multiple common susceptibility
variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part
of the missing heritability of colorectal cancer. PLoS Genet.
7:e10021052011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fernandez-Rozadilla C, de Castro L,
Clofent J, Brea-Fernandez A, Bessa X, et al: Single nucleotide
polymorphisms in the Wnt and BMP pathways and colorectal cancer
risk in a Spanish cohort. PLoS One. 5:e126732010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park SW, Hur SY, Yoo NJ and Lee SH:
Somatic frameshift mutations of bone morphogenic protein receptor 2
gene in gastric and colorectal cancers with microsatellite
instability. APMIS. 118:824–829. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Amedee J, Bareille R, Rouais F, Cunningham
N, Reddi H, et al: Osteogenin (bone morphogenic protein 3) inhibits
proliferation and stimulates differentiation of osteoprogenitors in
human bone marrow. Differentiation. 58:157–164. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Loh K, Chia JA, Greco S, Cozzi SJ,
Buttenshaw RL, et al: Bone morphogenic protein 3 inactivation is an
early and frequent event in colorectal cancer development. Genes
Chromosomes Cancer. 47:449–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen XR, Wang JW, Li X, Zhang H and Ye ZY:
Role of BMP3 in progression of gastric carcinoma in Chinese people.
World J Gastroenterol. 16:1409–1413. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kisiel JB, Yab TC, Taylor WR, Chari ST,
Petersen GM, et al: Stool DNA testing for the detection of
pancreatic cancer: assessment of methylation marker candidates.
Cancer. 118:2623–2631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai Z, Popkie AP, Zhu WG, Timmers CD,
Raval A, et al: Bone morphogenetic protein 3B silencing in
non-small-cell lung cancer. Oncogene. 23:3521–3529. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ronneberg JA, Fleischer T, Solvang HK,
Nordgard SH, Edvardsen H, et al: Methylation profiling with a panel
of cancer related genes: association with estrogen receptor, TP53
mutation status and expression subtypes in sporadic breast cancer.
Mol Oncol. 5:61–76. 2011. View Article : Google Scholar
|
|
22
|
Hotomi M, Sugitani I, Toda K, Kawabata K
and Fujimoto Y: A novel definition of extrathyroidal invasion for
patients with papillary thyroid carcinoma for predicting prognosis.
World J Surg. 36:1231–1240. 2012. View Article : Google Scholar : PubMed/NCBI
|
